Long-term clinical course in acute crescentic glomerulonephritis

Area of Science:

• Nephrology
• Pathology
• Immunology

Background:

• Acute crescentic glomerulonephritis, or rapidly progressive glomerulonephritis (RPGN), can rapidly lead to end-stage renal failure (ESRF).
• Histologically, RPGN involves glomerular inflammatory cell accumulation and epithelial cell proliferation.
• Type III immunopathogenic classification often indicates RPGN as a manifestation of systemic vasculitis.

Purpose of the Study:

• To evaluate the long-term outcomes of patients with acute crescentic glomerulonephritis.
• To determine the predictive value of early histopathologic diagnosis for renal prognosis.
• To assess the utility of a differentiated immunosuppressive therapy based on histopathology.

Main Methods:

• Investigated long-term results in 75 patients with acute crescentic glomerulonephritis.
• Utilized an activity and chronicity score system for histopathologic diagnosis.
• Compared outcomes with and without plasmapheresis in addition to immunosuppressive therapy.

Main Results:

• Early histopathologic diagnosis using activity and chronicity scores is a predictor of renal prognosis.
• Histopathologic scoring supports differentiated immunosuppressive therapy alongside clinical data.
• Plasmapheresis therapy did not demonstrate a proven therapeutic advantage when added to immunosuppressive treatment.

Conclusions:

• Early histopathologic diagnosis is crucial for predicting renal prognosis in RPGN.
• Histopathology-guided therapy allows for differentiated immunosuppressive treatment strategies.
• Current evidence does not support the routine use of plasmapheresis for RPGN in this context.